Reply

Affiliations

¹ Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE.
² University of Nebraska Medical Center Omaha, NE and National Data Bank for Rheumatic Diseases, Wichita, KS.
³ University of Nebraska Medical Center, Omaha, NE.

Comment

Brian W Coburn et al. Arthritis Rheumatol. 2018 Oct.

. 2018 Oct;70(10):1697-1698.

doi: 10.1002/art.40549. Epub 2018 Aug 23.

¹ Veterans Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE.
² University of Nebraska Medical Center Omaha, NE and National Data Bank for Rheumatic Diseases, Wichita, KS.
³ University of Nebraska Medical Center, Omaha, NE.

No abstract available

Comment on

Allopurinol Dose Escalation and Mortality Among Patients With Gout: A National Propensity-Matched Cohort Study.
Coburn BW, Michaud K, Bergman DA, Mikuls TR. Coburn BW, et al. Arthritis Rheumatol. 2018 Aug;70(8):1298-1307. doi: 10.1002/art.40486. Epub 2018 Jul 8. Arthritis Rheumatol. 2018. PMID: 29513934
Mounting Evidence Indicates That Escalating Doses of Allopurinol Are Unnecessary for Cardiovascular Protection: Comment on the Article by Coburn et al.
Bredemeier M. Bredemeier M. Arthritis Rheumatol. 2018 Oct;70(10):1696-1697. doi: 10.1002/art.40548. Epub 2018 Aug 23. Arthritis Rheumatol. 2018. PMID: 29740966 No abstract available.